Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses.
Kwan BH, Zhu EF, Tzeng A, Sugito HR, Eltahir AA, Ma B, Delaney MK, Murphy PA, Kauke MJ, Angelini A, Momin N, Mehta NK, Maragh AM, Hynes RO, Dranoff G, Cochran JR, Wittrup KD.
Kwan BH, et al. Among authors: wittrup kd.
J Exp Med. 2017 Jun 5;214(6):1679-1690. doi: 10.1084/jem.20160831. Epub 2017 May 4.
J Exp Med. 2017.
PMID: 28473400
Free PMC article.